GleamWall
中文EN

NEOG NEOGEN CORP

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 711377 · Fiscal year ends 05/31

Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.3%
TTM net income YoY94.6%
TTM EPS YoY94.6%
Revenue 3-yr CAGR-1.3%
Net income 3-yr CAGR—

Margins

Gross margin47.4%
Operating margin-0.8%
Net margin-6.3%
FCF margin5.6%
EBITDA margin12.3%

Returns

ROE-2.7%
ROA-1.7%
ROIC (approx.)-0.2%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets36.8%
Debt / equity0.74x
Current ratio3.90x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.52x
Accruals ratio-4.2%
Payout ratio—
Capex / revenue4.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-08-312026Q4*2026-05-312026Q32026-02-282026Q22025-11-302026Q12025-08-312025Q4*2025-05-312025Q32025-02-282025Q22024-11-30
Income statement
Revenue$222.80M$225.30M$211.20M$224.69M$209.20M$225.46M$220.98M$231.26M
Cost of revenue$117.30M$117.50M$112.20M$118.01M$114.20M$132.60M$110.70M$117.93M
Gross profit$105.50M$107.80M$99.00M$106.68M$95.00M$92.90M$110.30M$113.33M
R&D expense$6.50M$4.90M$3.80M$4.56M$5.10M$6.30M$4.50M$5.11M
SG&A expense$59.30M$58.70M$60.30M$65.21M$60.90M$53.00M$55.80M$57.77M
Operating income-$1.80M$3.10M-$3.30M-$5.38M-$16.10M-$611.20M$5.40M-$457.48M
Pretax income-$14.90M-$12.10M-$20.30M-$20.36M$43.80M-$631.20M-$9.70M-$476.57M
Income tax-$3.00M-$800,000-$3.30M-$4.44M$7.50M-$19.00M$1.20M-$20.29M
Net income-$11.90M-$11.30M-$17.00M-$15.92M$36.30M-$612.20M-$10.90M-$456.28M
EBITDA$27.30M$32.50M$25.62M$23.55M$13.00M-$580.90M$34.77M-$427.44M
EPS (basic)-0.05—-0.08-0.070.17—-0.05-2.10
EPS (diluted)-0.05—-0.08-0.070.17—-0.05-2.10
Weighted avg. shares (diluted)218.10M—217.67M217.41M217.30M—217.03M216.81M
Balance sheet
Cash & equivalents$172.00M$185.50M$159.90M$145.34M$138.80M$129.00M$127.70M$140.23M
Short-term investments—————$0$0$0
Receivables$136.20M$146.80M$137.10M$132.00M$138.46M$153.40M$160.07M$164.09M
Inventory$146.10M$144.30M$161.70M$162.77M$193.41M$190.80M$205.44M$198.27M
Current assets$582.50M$604.60M$590.00M$574.58M$524.06M$576.90M$551.71M$570.45M
PP&E, net$329.80M$329.80M$331.90M$332.36M$345.89M$339.10M$327.84M$310.55M
Goodwill$1.05B$1.05B$1.05B$1.05B$1.07B$1.06B$1.67B$1.67B
Intangibles$1.30B$1.32B$1.34B$1.36B$1.39B$1.41B$1.44B$1.46B
Total assets$3.30B$3.35B$3.36B$3.36B$3.38B$3.44B$4.04B$4.05B
Current liabilities$149.50M$158.20M$150.60M$147.05M$146.21M$174.00M$141.20M$151.19M
Short-term debt$780.00M$800.00M$800.00M$800.00M$800.00M$19.30M——
Long-term debt$774.20M$793.70M$793.30M$792.93M$792.53M$874.80M$890.61M$889.87M
Total debt$1.55B$1.59B$1.59B$1.59B$1.59B$894.10M$890.61M$889.87M
Total liabilities$1.22B$1.25B$1.26B$1.26B$1.26B$1.37B$1.38B$1.39B
Shareholders' equity$2.09B$2.09B$2.10B$2.10B$2.12B$2.07B$2.66B$2.67B
Net debt$1.38B$1.41B$1.43B$1.45B$1.45B$765.10M$762.90M$749.64M
Shares outstanding218.30M217.70M217.67M217.53M217.30M217.00M217.04M216.94M
Cash flow statement
Operating cash flow$12.90M$30.20M$22.70M$19.44M$10.80M$16.40M$19.36M$40.25M
Capital expenditure$8.20M$4.00M$11.63M$11.67M$24.00M$16.10M$32.87M$17.16M
Free cash flow$4.70M$26.20M$11.07M$7.78M-$13.20M$300,000-$13.51M$23.10M
Investing cash flow-$8.20M-$4.00M-$11.56M-$11.67M$97.70M-$15.90M-$32.45M-$17.16M
Financing cash flow-$19.00M-$300,000$744,000-$451,000-$99.40M-$2.10M$945,000-$1.41M
Depreciation & amortization$29.10M$29.40M$28.92M$28.93M$29.10M$30.30M$29.37M$30.05M
Stock-based compensation$3.10M$3.00M$1.10M$4.34M$5.00M$4.30M$4.16M$4.82M

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.